Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'20
Mar'19
Mar'18
Mar'17
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is -85.71% vs NA in Mar 2024
Other Long Term Liabilities
YoY Growth in year ended Mar 2025 is 0.00% vs NA in Mar 2024
Fixed Assets
YoY Growth in year ended Mar 2025 is -42.86% vs NA in Mar 2024
Investments
YoY Growth in year ended Mar 2025 is 0.00% vs NA in Mar 2024
Current Assets
YoY Growth in year ended Mar 2025 is 25,550.00% vs NA in Mar 2024
Compare Balance Sheet Results of Venmax Drugs
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
5.24
4.02
1.22
30.35%
Share Warrants & Outstandings
Total Reserve
-5.90
11.66
-17.56
-150.60%
Shareholder's Funds
4.41
15.68
-11.27
-71.88%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
1.38
-1.38
-100.00%
Secured Loans
0.00
0.40
-0.40
-100.00%
Unsecured Loans
0.00
0.98
-0.98
-100.00%
Deferred Tax Assets / Liabilities
0.00
0.01
-0.01
-100.00%
Other Long Term Liabilities
0.00
0.00
0.00
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.00
0.00
0.00%
Total Non-Current Liabilities
0.00
1.39
-1.39
-100.00%
Current Liabilities
Trade Payables
0.63
13.65
-13.02
-95.38%
Other Current Liabilities
0.08
0.77
-0.69
-89.61%
Short Term Borrowings
0.05
8.08
-8.03
-99.38%
Short Term Provisions
0.00
0.00
0.00
0.00%
Total Current Liabilities
0.76
22.49
-21.73
-96.62%
Total Liabilities
5.17
39.55
-34.38
-86.93%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
0.04
2.85
-2.81
-98.60%
Less: Accumulated Depreciation
0.00
0.34
-0.34
-100.00%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
0.04
2.51
-2.47
-98.41%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
8.61
-8.61
-100.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
0.34
-0.34
-100.00%
Long Term Loans & Advances
0.00
0.88
-0.88
-100.00%
Other Non Current Assets
0.00
0.00
0.00
0.00%
Total Non-Current Assets
0.04
12.34
-12.30
-99.68%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
0.06
0.10
-0.04
-40.00%
Sundry Debtors
0.95
26.58
-25.63
-96.43%
Cash and Bank
2.48
0.33
2.15
651.52%
Other Current Assets
0.03
0.16
-0.13
-81.25%
Short Term Loans and Advances
1.61
0.05
1.56
3,120.00%
Total Current Assets
5.13
27.22
-22.09
-81.15%
Net Current Assets (Including Current Investments)
4.37
4.73
-0.36
-7.61%
Total Current Assets Excluding Current Investments
5.13
27.22
-22.09
-81.15%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
5.17
39.55
-34.38
-86.93%
Contingent Liabilities
0.00
0.00
0.00
0.00%
Total Debt
0.05
9.46
-9.41
-99.47%
Book Value per share (adjusted)
-1.26
38.99
-40.25
-103.23%
Annual - Borrowings
Borrowings 0.05 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -85.71% vs NA in Mar 2024
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
YoY Growth in year ended Mar 2025 is 0.00% vs NA in Mar 2024
Annual - Fixed Assets
Fixed Assets 0.04 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -42.86% vs NA in Mar 2024
Annual - Investments
No Investments in the last few periods
YoY Growth in year ended Mar 2025 is 0.00% vs NA in Mar 2024
Annual - Current Assets
Current Assets 5.13 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 25,550.00% vs NA in Mar 2024






